ORGANIZATIONAL SKILLS INTERVENTION FOR ADHD CHILDREN

描述(申请人摘要)：除ADHD的基本体征外， 人们普遍认为，其他临床特征也很重要，包括 组织任务和活动的问题，杂乱无章的工作习惯，以及 容易丢失材料。ADHD的一个杰出模型认识到了这些问题 因为这反映了行政职能的缺陷。然而，系统的步骤已经 没有被用来评估或干预改善组织、时间 管理、规划(OTMP)技能。这份R21意见书建议开发 改善8~11岁儿童OTMP技能缺陷的干预措施 患有多动症。这个应用程序有三个主要目的：1)仪器开发；2) 治疗发展；以及3)中试干预试验。第一个目标是 开发OTMP技能的“现实生活”测量方法：1)确定特定领域 损害；2)评估治疗结果。我们计划两个评估战略： 儿童组织技能量表与儿童组织能力的模拟测验 组织能力。我们的第二个目标是开发一种人工干预 旨在通过改善OTMP技能来改善学校和家庭的功能。 我们的第三个目标是进行一项试验性治疗研究，在这项研究中，20名儿童 被分配到为期10周的OTMP治疗组和20名只接受评估的对照组 一群人。这项初步研究的目的是生成数据来估计效果大小 需要进行全面的临床试验。如果证明有效， 适当的研究设计，治疗意在作为一个重要的 作为ADHD其他有效治疗方法的补充。它是一个附加词，它是 因此，这一领域的创新似乎至关重要。

DESCRIPTION (Applicant's abstract): In addition to the cardinal signs of ADHD, it is generally recognized that other clinical features are crucial including problems in organizing tasks and activities, disorganized work habits, and a tendency to lose materials. A prominent model of ADHD recognizes these problems as reflecting deficits in executive functions. However, systematic steps have not been taken to assess or intervene in improving organizational, time management, and planning (OTMP) skills. This R21 submission proposes to develop an intervention to ameliorate the OTMP skill deficits in 8-11 year old children with ADHD. This application has three major aims: 1) instrument development; 2) treatment development; and 3) pilot intervention testing. The first aim is to develop "real life" measures of OTMP skills to: 1) identify specific areas of impairment; and 2) assess treatment outcome. We plan two assessment strategies: the Children's Organizational Skills Scale and the Analogue Test of Organization Skills. Our second aim is to develop a manualized intervention designed to improve functioning at school and home by ameliorating OTMP skills. Our third aim is to conduct a pilot treatment study in which 20 children are assigned to a 10-week OTMP treatment group and 20 to an assessment only control group. The pilot study is designed to generate data to estimate effect sizes needed to conduct a full-scale clinical trial. If proven effective in appropriate study designs, the treatment is intended to serve as an important adjunct to other validated treatments for ADHD. It is an adjunct that is currently missing, so innovation in this area seems crucial.